Clinical Trial Update: DC Migration Study for Newly-Diagnosed GBM [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on dendritic cell migration for newly diagnosed glioblastoma; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma Grade Iv
• Giant Cell Glioblastoma
• Glioblastoma
• Glioblastoma Multiforme

Snippet

Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP | Conditions: Glioblastoma, Astrocytoma, Grade IV | Phase 2 | Status: COMPLETED | Results posted: 2022-02-01